Loading organizations...
Inventages is a venture capital firm strategically investing in life sciences, nutrition, and wellness. It provides capital to early-stage companies developing enabling technologies and services, including novel packaging, advanced production, and innovative materials. The firm combines financial backing with strategic guidance, accelerating innovation across consumer goods and health industries.
Founded in 2000 by Dr. Gunnar Weikert, Inventages began as Nestlé's corporate venturing unit in London. Dr. Weikert, drawing on prior experience, established the firm to foster early-stage innovation in life science and consumer health through strategic capital. This allowed Nestlé to invest in key technologies aligned with its business objectives.
Inventages supports emerging life science, nutrition, and wellness companies needing capital and expertise. The firm’s vision is to drive significant advancements within these fields. Facilitating new solution development and commercialization, Inventages aims to enhance human health and well-being, fostering sustainable growth via targeted investments.
Key people at Inventages.
Inventages was founded in 2000 by Gunnar Weikert (Chairman, CEO and Founder).
Inventages was founded in 2000 by Gunnar Weikert (Chairman, CEO and Founder).
Inventages has 5 tracked investments across 5 companies. The latest tracked deal is $50.0M Other Equity in Cerecin in October 2018.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Oct 4, 2018 | Cerecin | $50.0M Other Equity | Wilmar International | — |
| Sep 11, 2014 | AM Pharma | $15.8M Other Equity | — | AbbVie Ventures, BB Biotech Ventures, Idinvest Partners, Kurma Partners, Ysios Capital |
| Sep 2, 2014 | GC-Rise Pharmaceutical | $15.0M Rise Pharmaceutical - Series B | Jonathan Wang | Yifang Group |
| Nov 19, 2010 | MooBella | $9.0M Other Equity | Inventages | — |
| Oct 23, 2008 | Cognoptix | $18.5M Other Equity | — | Launchpad Venture Group |
Key people at Inventages.
